Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 15.09.2025 4 Antiviral Res 1 Drug Saf 1 J Infect Dis 3 J Virol 2 JAMA 1 MMWR Morb Mortal Wkly Rep 15 PLoS One 2 Proc Natl Acad Sci U S A 3 Vaccine 8 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. ICHIKAWA T, Tamura T, Nao N, Suzuki H, et al
   Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.
   Antiviral Res. 2025;242:106264.
   PubMed         Abstract available
   
   
2. BI W, Zhu T, Xu Y, Chen Y, et al
   An engineered chimeric ACE2-HR2 peptide exhibits potent and broad-spectrum activity against SARS-CoV-2 variants.
   Antiviral Res. 2025;242:106265.
   PubMed         Abstract available
   
   
3. TERATAKE Y, Okamura T, Ishizaka Y
   SMAD5 phosphorylation by ALK1 is modulated by the interaction of the spike protein of SARS-CoV-2 and angiotensin-converting enzyme 2.
   Antiviral Res. 2025;242:106261.
   PubMed         Abstract available
   
   
4. YAO G, Shi X, Jiang H, Duan A, et al
   Design, synthesis, and biological evaluation of novel 6-aminoalkyl- and 7-heteroaryl substituted 7-deazapurine nucleoside analogs against SARS-CoV-2 Replication.
   Antiviral Res. 2025 Aug 1:106246. doi: 10.1016/j.antiviral.2025.106246.
   PubMed         Abstract available
   
   

   
   Drug Saf

5. ORDONEZ-MENA JM, Kar D, Fan X, Ferreira F, et al
   Epidemiology of Thrombotic Thrombocytopenia Syndrome 2011 to 2022: English Sentinel Network Cohort Studies.
   Drug Saf. 2025;48:1161-1175.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. BERMEJO-JAMBRINA M, Zaderer V, Eder J, Diem G, et al
   The Role of Enoxaparin in Influenza Virus Infections and Its Therapeutic Implications.
   J Infect Dis. 2025 Sep 10:jiaf470. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

7. FAN W, Zeng X, Chen Y, Yu Q, et al
   A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens.
   J Virol. 2025 Sep 11:e0114925. doi: 10.1128/jvi.01149.
   PubMed         Abstract available
   
   
8. LAN R, Yang J, Li J, Li H, et al
   Continuous evolution of Eurasian avian-like H1N1 swine influenza viruses with pdm/09-derived internal genes enhances pathogenicity in mice.
   J Virol. 2025 Sep 8:e0043025. doi: 10.1128/jvi.00430.
   PubMed         Abstract available
   
   
9. NAKANO M, Miyamoto S, Ohnishi C, Nogami C, et al
   Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.
   J Virol. 2025 Sep 8:e0073725. doi: 10.1128/jvi.00737.
   PubMed         Abstract available
   
   

   
   JAMA

10. LIU Z, Zhang L, Jiang M
    Influenza and COVID-19 Multicomponent Vaccine in Adults.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
    PubMed        
    
    
11. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
    Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

12. O'HALLORAN A, Habeck JW, Gilmer M, Threlkel R, et al
    Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:529-537.
    PubMed         Abstract available
    
    

    
    PLoS One

13. MUHUNDHAKUMAR D, Clarke CS, Mills G, Ramsay AIG, et al
    Cohort profile: Design and methods for Project HERCULES (Healthcare Exemplar for Recovery from COVID 19 Using Linear Examination Systems): Multi-disciplinary implementation and evaluation of an asynchronous review clinic in NHS eye-care services.
    PLoS One. 2025;20:e0330863.
    PubMed         Abstract available
    
    
14. CHOI J, Son G, Kim YS, Choi KH, et al
    Impact of depression, anxiety, and COVID-19 diagnosis on social isolation trajectories during the pandemic: A 3-year prospective cohort study.
    PLoS One. 2025;20:e0330118.
    PubMed         Abstract available
    
    
15. RUDISILL C, Linvill K, Chupak A, Costa-Font J, et al
    Trust or money? Barriers to health and healthcare behavior during the COVID-19 pandemic.
    PLoS One. 2025;20:e0331600.
    PubMed         Abstract available
    
    
16. GANGULY AP, Battaile JT, Harms M, Murray S, et al
    Charity coverage and decreased COVID-19 mortality among uninsured patients in Texas: A retrospective cohort study.
    PLoS One. 2025;20:e0330533.
    PubMed         Abstract available
    
    
17. WILLEN SS, Mason KA, Wurtz HM, Karcher S, et al
    The Pandemic Journaling Project: A new dataset of first-person accounts of the COVID-19 pandemic.
    PLoS One. 2025;20:e0318397.
    PubMed         Abstract available
    
    
18. LI Y, Sexton CL, Fitzpatrick A, Ruple A, et al
    An analysis of behavioral characteristics and enrollment year variability in 47,444 dogs entering the Dog Aging Project from 2020 to 2023.
    PLoS One. 2025;20:e0330257.
    PubMed         Abstract available
    
    
19. DURANT EJ, Warton EM, Skarbinski J, Siqueiros MH, et al
    Predictors of health care utilization in patients with post-acute sequelae of COVID-19 (PASC).
    PLoS One. 2025;20:e0331370.
    PubMed         Abstract available
    
    
20. GARBIN JRT, Leite FMC, Santos APBD, Dell'Antonio LS, et al
    Factors associated with prolonged hospitalizations for COVID-19 during the first three waves of the pandemic: Evidence from a Southeastern State of Brazil.
    PLoS One. 2025;20:e0332128.
    PubMed         Abstract available
    
    
21. RABAGLIATI R, Benadof D, Thompson L, Garcia P, et al
    A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.
    PLoS One. 2025;20:e0330426.
    PubMed         Abstract available
    
    
22. KIM D, Kim T, Kim W, Youn H, et al
    When automation hits jobs: Entrepreneurship as an alternative career path.
    PLoS One. 2025;20:e0331244.
    PubMed         Abstract available
    
    
23. ELSNER A, Mergl R, Allgaier AK, Hegerl U, et al
    Suicide rates in Germany in lockdown and non-lockdown phases during the COVID-19 pandemic in 2020/2021.
    PLoS One. 2025;20:e0331784.
    PubMed         Abstract available
    
    
24. KIM J, Ewing CR, Larson A, Illapperuma-Wood C, et al
    Incidence of depression and anxiety in children and adolescents following COVID-19 infection.
    PLoS One. 2025;20:e0331984.
    PubMed         Abstract available
    
    
25. MURPHY M, Friciu M, Roullin VG, Leclair G, et al
    Propofol emulsification in Intralipid and SMOFlipid: A promising alternative in response to future shortages.
    PLoS One. 2025;20:e0331651.
    PubMed         Abstract available
    
    
26. XIA B, Pierce BS, Perrin PB
    Examining models of telemedicine use among U.S. physicians during the COVID-19 pandemic.
    PLoS One. 2025;20:e0331832.
    PubMed         Abstract available
    
    
27. DELL'ANTONIO CSDS, Bierrenbach AL
    Epidemiological patterns of SARS-CoV-2 reinfections in Espirito Santo, Brazil: A population-based analysis using integrated surveillance and vaccination data.
    PLoS One. 2025;20:e0331771.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

28. LINOS E, Lasky-Fink J, Dorie V, Rothstein J, et al
    Interventions to bolster benefits take-up: Assessing intensity, framing, and targeting of government outreach.
    Proc Natl Acad Sci U S A. 2025;122:e2504747122.
    PubMed         Abstract available
    
    
29. JIANG Z, Pan W, Chen Y, Zhou D, et al
    ApoD mediates age-associated increase in vulnerability to influenza virus infection.
    Proc Natl Acad Sci U S A. 2025;122:e2423973122.
    PubMed         Abstract available
    
    

    
    Vaccine

30. HUANG YT, Tsou TP, Kuo SH, Huang YT, et al
    Assessment of influenza vaccine effectiveness among the elderly in Taiwan using population-based registry data for the 2023-2024 season.
    Vaccine. 2025;64:127690.
    PubMed         Abstract available
    
    
31. BARBERIA LG, Seelaender ICR, Carvalho RJ, de Moraes JC, et al
    Caregivers' attitudes toward school-based vaccination programs: A comparison of COVID-19, HPV, influenza, and dengue vaccines in Brazil.
    Vaccine. 2025;64:127709.
    PubMed         Abstract available
    
    
32. SANFTENBERG L, Kraeker L, Walter F, Tsiligianni I, et al
    Associations between common mental disorders and vaccination readiness against seasonal influenza and Covid-19 of chronically ill adult patients in primary care - a systematic review.
    Vaccine. 2025;64:127682.
    PubMed         Abstract available
    
    

    
    Virology

33. SILVA MO, Daher IP, Oda Ibrahim CH, de Souza EE, et al
    Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.
    Virology. 2025;611:110629.
    PubMed         Abstract available
    
    
34. LU CY, Lai PY, Huang JM, Chang LY, et al
    Dual targeting of the Wnt and DNAJB6/MRJ regulatory loop as an anti-RSV strategy.
    Virology. 2025;611:110641.
    PubMed         Abstract available
    
    
35. LUCINI PAIONI A, Donnici L, Nodari R, Longo Minnolo M, et al
    A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.
    Virology. 2025;611:110659.
    PubMed         Abstract available
    
    
36. RAVINDRAN C, Mukherjee S
    Zebrafish as a model for SARS-CoV-2 infection, pathogenesis, transmission, and drug screening.
    Virology. 2025;611:110662.
    PubMed         Abstract available
    
    
37. CHINNA P, Blumenthal MJ, Lambarey H, Jennings L, et al
    Assessment of gamma-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa.
    Virology. 2025;611:110666.
    PubMed         Abstract available
    
    
38. KIM KH, Hwang HS, Lee Y, Jung YJ, et al
    Interferon-gamma receptor signaling is critical for balanced immune activation and protection against influenza after vaccination.
    Virology. 2025;612:110674.
    PubMed         Abstract available
    
    
39. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    PubMed         Abstract available
    
    
40. PAWAR SD, Tare DS, Keng SS, Walimbe AM, et al
    Tracing the possible origins of the clade 2.3.4.4b highly pathogenic avian influenza H5Nx viruses from India.
    Virology. 2025 Aug 29:110654. doi: 10.1016/j.virol.2025.110654.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.